Cargando…
COVID‐19 Hospitalization Outcomes Among Patients With Autoimmune Rheumatic Diseases in the United States
OBJECTIVES: To investigate the outcomes of COVID‐19‐related hospitalizations among patients with autoimmune rheumatic diseases (ARDs) in the United States in 2020. The primary outcome was in‐hospital mortality, and secondary outcomes included intubation rate, length of hospital stay (LOS), and total...
Autores principales: | Khalaf, Ahmad, Ibrahim, Garad, Goble, Spencer, Kuijpers, Marcela, Nasr, Rawad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349215/ https://www.ncbi.nlm.nih.gov/pubmed/37312632 http://dx.doi.org/10.1002/acr2.11572 |
Ejemplares similares
-
Autoimmune Rheumatic Diseases
por: Anaya, Juan-Manuel, et al.
Publicado: (2014) -
Latent rheumatic, thyroid and phospholipid autoimmunity in hospitalized patients with COVID-19
por: Anaya, Juan-Manuel, et al.
Publicado: (2021) -
Long COVID in autoimmune rheumatic diseases
por: Fedorchenko, Yuliya, et al.
Publicado: (2023) -
Curcumin in Autoimmune and Rheumatic Diseases
por: Yang, Melissa, et al.
Publicado: (2019) -
Undifferentiated vasculitis or an evolving systemic autoimmune rheumatic disease?
por: Fatimah, Nafeesah, et al.
Publicado: (2016)